Hatchtech Pty Ltd

Hatchtech Pty Ltd

Private
CamberwellHealthcare & Life Scienceshttps://hatchtech.com.au

Last Round

M&A

Sep 14, 2015

Est. Valuation

$197M

Total Funding Raised

$18.38M

Momentum Score

25 /100

Company Overview

Hatchtech Pty Ltd is a pharmaceutical company that has developed Xeglyze, an FDA-approved topical lotion for the treatment of head lice infestation.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Clinical Trials, Pharma Supply Chain

Business Model

B2B

Customer Profile

Revenue Share

AI Layer

Non-AI

Keywords

head lice treatmentprescription head lice treatmentsingle application lice treatmentpharmaceutical licensingdrug developmentspecialty pharmaovicidal treatmentabametapirout-licensingFDA approvalpediculosis treatmentsuper lice treatmentbiotechnologytopical treatment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Hatchtech Pty Ltd Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Hatchtech Pty Ltd Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
M&ASep 14, 2015
Series BOct 31, 2013
VC RoundDec 12, 2012
Series AOct 26, 2010

Hatchtech Pty Ltd Investors

Notable investors and investment history

InvestorRounds
OneVenturesM&A, Series A, Series B, VC Round
GBS Venture PartnersSeries A, VC Round, M&A, Series B
University of MelbourneSeries A, VC Round, Series B
QIC BioventuresSeries B
UniseedSeries A, M&A, Series B, VC Round, Seed
Brisbane AngelsVC Round
AustralianSuperM&A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2026

    Monthly visitors increased 59% MoM.

Hatchtech Pty Ltd Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Hatchtech Pty Ltd Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Hatchtech Pty Ltd's valuation, stock price, and market status.

Firmographic Details

HeadquartersCamberwell
Employee Range5
Year Founded2001
Last FundingSep 14, 2015

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.